Professional Documents
Culture Documents
Original articles
Thorax: first published as 10.1136/thx.51.7.661 on 1 July 1996. Downloaded from http://thorax.bmj.com/ on May 6, 2023 by guest. Protected by copyright.
Pulse therapy with cyclophosphamide and
methylprednisolone in patients with moderate
to severe paraquat poisoning: a preliminary
report
Thorax: first published as 10.1136/thx.51.7.661 on 1 July 1996. Downloaded from http://thorax.bmj.com/ on May 6, 2023 by guest. Protected by copyright.
M:F 9:8 7:9 p value of <0 05 was considered significant.
Acute renal failure* 10 (5888%) 10 (62 5%)
Serum creatinine (jsmol/l)* 209 2 (130-8) 189-8 (105-0)
Hepatitis* 5 (2944%) 6 (37-5%)
Serum alanine aminotransferase (ALT) (U/l)* 36-5 (18 8) 35-6 (46 8)
Hypoxia* 3 (17-6%) 4 (25%) Results
Arterial blood Pao2 at room air (kPa)* 10 9 (2-0) 11-7 (1-8) Of the 33 patients enrolled in the study, most
Mortality 12 (7066%) 4 (25%)t
were young adults. All were suicidal and had
* Biochemical data of renal, liver, and lung functions on the third day after paraquat ingestion ingested 24% liquid paraquat concentrate.
(for definition see Methods section).
t p<0-02 (X2 with Fisher's exact test). There were no differences between the groups
in age, sex, time elapsed from ingestion to
arrival at the emergency room (6-41 (6 57)
versus 6-00 (5 80) hours), the beginning of
haemoperfusion (8-59 (7 38) versus 8-29
therefore classified as having moderate to severe (5-69) hours) or the timing of urine paraquat
poisoning if the urinary dithionite reaction tests following ingestion (7-00 (6 93) versus
yielded a navy blue or dark blue colour, or 6-21 (4.55) hours), and the severity of paraquat
mild poisoning if the urine paraquat tests were poisoning (seven "navy blue" and nine "dark
colourless or light blue.10 There were no blue" versus six "navy blue" and 11 "dark
facilities to measure plasma levels of paraquat. blue"). There was no difference in the in-
From July 1992 to June 1994 41 patients cidence of acute renal failure, hepatitis, or hyp-
with paraquat poisoning were admitted, 16 of oxia on the third day following paraquat
whom had moderate to severe poisoning and ingestion in the two groups (table).
were admitted within 24 hours of ingestion and The fatality rate was significantly lower in
survived for more than three days. These were the treatment group (25%) than in the control
enrolled in the study and were treated with group 12/17 (70-6%) (p <001, x2 test; cor-
pulse therapy of cyclophosphamide and rected by Fisher's exact test, p <0.02). All
methylprednisolone. Thirteen patients with ful- fatalities were from respiratory failure.
minant poisoning and 12 with mild poisoning Leucopenia (white blood count <3000) was
were excluded. The control group comprised the only major complication of pulse therapy
17 patients with moderate to severe poisoning, and occurred in six of the 16 cases (37-5%),
who were admitted within 24 hours of ingestion but in all spontaneous recovery was complete
and who survived for three days, of the total of within one week. Pulse therapy was well tol-
46 admitted with paraquat poisoning between erated, although minor complications in-
July 1989 and June 1991. Eleven patients with cluding hair loss and acne were noted in some
fulminant poisoning who died within three days patients.
of intoxication and 18 patients with mild pois-
oning were excluded.
Discussion
These data suggest that pulse therapy with
TREATMENT PROTOCOL cyclophosphamide and methylprednisolone
After gastric lavage with normal saline, active improves the prognosis of patients with mod-
charcoal in magnesium citrate solution was erate to severe paraquat poisoning. All deaths
given to both groups of patients through a were from progressive respiratory failure and a
nasogastric tube to prevent further absorption reduction in inflammatory change in the lungs
of paraquat from the gastrointestinal tract. All is the likely mechanism. There were no severe
patients were haemoperfused for eight hours complications, which suggests that it is safe
within 24 hours of paraquat ingestion. In the and well tolerated. Retrospective studies1 1-2
treatment group all patients received 1 g cyclo- have shown that both plasma and urine con-
phosphamide daily for two days and 1 g methyl- centrations of paraquat within the first 24 hours
prednisolone daily for three days following of intoxication are good predictors of outcome.
haemoperfusion. The infusions were ad- The absence of plasma paraquat concentrations
ministered over two hours. Arterial blood gas is a limitation of this study, but plasma paraquat
tensions, white cell count, serum creatinine levels fall very quickly after an overdose and
levels, chest radiography, and liver function an error of an hour in the estimate of the time
tests were regularly checked. of ingestion can mean a change in survival from
30% to 70%." The urine dithionite test can
be performed easily and quickly, giving a reas-
DEFINITIONS6 onable guide to the severity of poisoning and
Patients were considered to have developed likely prognosis4 at the time of admission.
acute renal failure if the serum creatinine level In conclusion, our results suggest that pulse
rose above 130 pmol/l or hepatitis if serum therapy with cyclophosphamide and methyl-
alanine aminotransferase (ALT) levels were prednisolone may be an effective and safe way
>70 U/l (normal value <35 U/l) or total bili- to treat patients with moderate to severe para-
rubin was >35 pmol/l. Patients were considered quat poisoning as determined by the urine
to be hypoxic if the arterial oxygen tension dithionite test. Prospective controlled studies
(Pao2) when breathing room air was <9 kPa. are required to confirm this observation.
Paraquat poisoning and pulse therapy 663
1 Vale JA, Meredith TJ, Buckle BM. Paraquat poisoning: cyclophosphamide in severe lupus nephritis. Lancet 1992;
clinical features and immediate general management. Hum 340:741-5.
Toxicol 1987;6:4-17. 8 McCune WJ, Golbus J, Zeldes W, Bohlke P, Dunne R,
2 Bateman DN. Pharmacological treatments of paraquat pois- Fox DA. Clinical and immunologic effects of monthly
oning. Hum Toxicol 1987;6:57-62. administration of intravenous cyclophosphamide in severe
3 Talbot AR, Barnes MR. Radiotherapy for the treatrnent of systemic lupus erythematosus. N Engl J7 Med 1988;318:
pulmonary complications of paraquat poisoning. Hum
1423-31.
9 Hoffman GS, Leavitt RY, Fleisher TA, Fauci AS. Treatments
Toxicol 1988;7:325-32.
Thorax: first published as 10.1136/thx.51.7.661 on 1 July 1996. Downloaded from http://thorax.bmj.com/ on May 6, 2023 by guest. Protected by copyright.
of Wegener's granulomatosis with intermittent high-dose
4 Hampson ECGM, Pond SM. Failure of hemoperfusion and intravenous cyclophosphamide. Am Med 1990;89:403-
hemodialysis to prevent death in paraquat poisoning: a 10.
retrospective review of 42 patients. Med Toxicol 1988;3: 10 Scherrmann JM, Houze P, Bismuth C, Bourdon R. Prog-
64-71. nostic value of plasma and urine paraquat concentrations.
5 Addo E, Poon-King T. Leukocyte suppression in treatment Hum Toxicol 1987;6:91-3.
of 72 patients with paraquat poisoning. Lancet 1986;i: 11 Proudfoot AT, Stewart MS, Levitt T, Widdop B. Paraquat
1117-20. poisoning: significance of plasma paraquat concentrations.
6 Perriens JH, Benimadho S, Lie Kiaw I, Wisse J, Chee Lancet 1979;ii:330-2.
H. High dose cyclophosphamide and dexamethasone in 12 Hart TB, Nevitt A, Whitehead A. A new statistical approach
to the prognostic significance of plasma concentrations.
paraquat poisoning: a prospective study. Hum Exp Toxicol Lancet 1984;ii: 1222-3.
1992;11:129-34. 13 Editorial. Cyclophosphamide for paraquat poisoning? Lancet
7 Boumpas DT, Austin III HA, Vaughn EM, Klippel JH, 1986;ii:375-6.
Steinberg AD, Yarboro CH, et al. Controlled trial of 14 Braithwaite RA. Emergency analysis of paraquat in bio-
pulse methylprednisolone versus two regimens of pulse logical fluids. Hum Toxicol 1987;6:83-6.